Revenue cycle management solutions provider MBX Medical Billing Experts has rolled out a new healthcare data analytics tool aimed at helping provider organizations maximize financial and operational ...
Zacks Investment Research on MSN
Wall Street Analysts See a 142% Upside in MBX Biosciences, Inc. (MBX): Can the Stock Really Move This High?
MBX Biosciences, Inc. (MBX) closed the last trading session at $24.07, gaining 74.8% over the past four weeks, but there ...
TipRanks on MSN
MBX Biosciences initiated with a Buy at TD Cowen
TD Cowen initiated coverage of MBX Biosciences (MBX) with a Buy rating and no price target The firm believes the company’s Prostate Secretory ...
Company is the third biotech to set price ranges for planned deals since Friday MBX Biosciences (MBX), a clinical-stage biotech focused on developing treatments for endocrine and metabolic disorders, ...
MBX Biosciences (MBX) announced the publication of a peer-reviewed article highlighting results from the Phase 1 study of MBX 2109, the Company’s parathyroid hormone peptide prodrug in development for ...
CARMEL, Ind., June 16, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide ...
MBX Biosciences, a Carmel startup that has raised an eye-popping $150 million in venture funding, has received clearance from federal regulators to move its second experimental drug into human testing ...
MBX Biosciences MBX, a clinical-stage biotech focused on developing treatments for endocrine and metabolic disorders, set terms for its initial public offering on Monday, with plans to offer 8.5 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback